Blood and Marrow Transplant Program | Cellular Therapies Program

illustration of stem cells and DNA helix In collaboration with Robert Wood Johnson University Hospital, an RWJBarnabas Health facility, the Transplant and Cellular Therapy Program at Rutgers Cancer Institute of New Jersey has been performing autologous and allogeneic stem cell transplants since 1995. Ours is the only such program in New Jersey offered at an NCI-designated Comprehensive Cancer Center.

The program treats patients with a number of illnesses including acute and chronic leukemias, myelodysplasia, lymphomas, Hodgkin disease, multiple myeloma, amyloidosis, and others. Our oncologists are experts in Blood and Marrow Transplants (BMT), CAR T-Cell therapy, cellular therapy and more.

The clinical and research interests of our clinicians focus on novel strategies to prevent graft-versus-host disease, improve umbilical cord blood transplants, and develop cellular therapies that are less toxic than standard transplants.

The Transplant and Cellular Therapy Program is accredited by the National Marrow Donor Program and the Foundation for the Accreditation of Cellular Therapy (FACT). It has been rated “Excellent” by the American College of Surgeons. We offer a full suite of oncology support services through which Oncology Nurse Navigators and transplant coordinators guide patients through treatment and beyond.

To request an appointment, call 844-CANCERNJ. | Find a Clinical Trial

Your Transplant and Cellular Therapy Team

Ira Braunschweig, MD

Chief, Section of Transplant and Cell Therapy, Rutgers Cancer Institute
Chief of the Transplant and Cell Therapy Service of the RWJBarnabas Health Oncology Service Line
Director for Cell Therapy and Bone Marrow Transplantation at Robert Wood Johnson University Hospital
Professor of Medicine at Rutgers Robert Wood Johnson Medical School

Amer Assal, MD

Associate Professor, Department of Medicine
Hematologist/Oncologist

Andrew M. Evens, DO, MBA, MSc

Associate Director for Clinical Services, Rutgers Cancer Institute;
System Director of Medical Oncology and Oncology Lead for Combined Medical Group, RWJBarnabas Health;
Associate Vice Chancellor for Clinical Innovation and Data Analytics, Rutgers Biomedical and Health Sciences